Biologists identify promising drug for ALS treatment

A drug typically used to treat hepatitis could slow the progression of ALS, also known as Lou Gehrig’s disease, according to new research by University of Alberta scientists. The drug, called telbivudine, targets a protein called SOD1 that misfolds in most cases of patients with ALS. “We showed that telbivudine can greatly reduce the toxic properties of SOD1, including improving […]

Read more